A pharmaceutical study on certain modified release etodolac dosage forms / Ahmed Adel Mohamed Alaa Eldin ; Supervised Ahmed Abdelbary Abdelrahman , Mina Ibrahim Tadros

By:

Ahmed Adel Mohamed Alaa Eldin

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Ahmed Adel Mohamed Alaa Eldin , 2010Description: 200 P. : charts ; 25cmOther title:

دراسة صيدلية على بعض الأشكال الصيدلية محورة الأنطلاق لعقار الإيتودولاك [Added title page title]

Subject(s):

Online resources:

Click here to access online

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics Summary: Etodolac is non - steroidal anti - inflammatory drug acting by a preferential inhibition of cyclo - oxygenase - 2 ( COX - 2 ) enzyme . It is used for rheumatoid arthritis , including juvenile idiopathic arthritis , osteoathritis and for the treatment of acute pain . It has an elimination half - life of 7 hour and the recommended oral dose , 200 to 400 mg, is given every 6 to 8 hours to a maximum of 1.2 g daily , therefore it is a potential cadidate for controlled release formulations

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.08.08.M.Sc.2010.Ah.P (Browse shelf(Opens below))		Not for loan	01010110054638000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.08.08.M.Sc.2010.Ah.P (Browse shelf(Opens below))	54638.CD	Not for loan	01020110054638000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.08.08.M.Sc.2010.Ah.L Labelling and quality control of some ⁹⁹ {u036B} Tc-radiopharmaceuticals of expected biological activity	Cai01.08.08.M.Sc.2010.Ah.L Labelling and quality control of some ⁹⁹ {u036B} Tc-radiopharmaceuticals of expected biological activity	Cai01.08.08.M.Sc.2010.Ah.P A pharmaceutical study on certain modified release etodolac dosage forms /	Cai01.08.08.M.Sc.2010.Ah.P A pharmaceutical study on certain modified release etodolac dosage forms /	Cai01.08.08.M.Sc.2010.Al.D Design and evaluation of topical drug delivery system /	Cai01.08.08.M.Sc.2010.Al.D Design and evaluation of topical drug delivery system /	Cai01.08.08.M.Sc.2010.Am.P A pharmaceutical study on celecoxib /	Next

Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics

Etodolac is non - steroidal anti - inflammatory drug acting by a preferential inhibition of cyclo - oxygenase - 2 ( COX - 2 ) enzyme . It is used for rheumatoid arthritis , including juvenile idiopathic arthritis , osteoathritis and for the treatment of acute pain . It has an elimination half - life of 7 hour and the recommended oral dose , 200 to 400 mg, is given every 6 to 8 hours to a maximum of 1.2 g daily , therefore it is a potential cadidate for controlled release formulations

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer